Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU

NCT ID: NCT05922085

Last Updated: 2025-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-09

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Swallowing disorders (SD) are particularly common after extubation in the ICU and may be associated with an increased risk of lung disease, increased length of hospital stay, and a higher risk of early reintubation. In contrast, early detection of SDs has been shown to be associated with a decrease in these complications. Thus, there is a need for rapid and reliable assessment of SDs in ICU patients before the withdrawal of mechanical ventilation.

Videofluoroscopy (VFS) and nasofibroscopy (NF) are the gold standard examinations for diagnosing SD. However, these two examinations are not feasible in intubated patients.

In this context, ultrasound appears to be a promising alternative to identify patients at risk of SD after extubation. This examination can be performed at the intubated patient's bedside and can be used evaluate the mobility of the structures involved in swallowing. Many studies have already shown the interest of ultrasound in the evaluation of SD but none has focused on intubated patients under respiratory assistance.

The objective of the present study is to evaluate the value of ultrasound in identifying patients at risk of presenting SD after extubation.

This monocentric study will take place in the Intensive Care Unit (ICU) of the Dijon University Hospital. The duration of participation in this research will be equal to the length of stay in the ICU. During their stay, patients will undergo ultrasound and nasofibroscopy. Information on the characteristics of the ICU stay will be collected at discharge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Under Mechanical Ventilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patient under mechanical ventilation for at least 48 hours

Group Type EXPERIMENTAL

Ultrasound

Intervention Type OTHER

performed within 3 hours prior to extubation

nasofibroscopie

Intervention Type OTHER

performed within 24 to 36 hours after extubation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

performed within 3 hours prior to extubation

Intervention Type OTHER

nasofibroscopie

performed within 24 to 36 hours after extubation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patient:

* Major
* On mechanical ventilation for at least 48 hours
* Affiliated to national health insurance

Exclusion Criteria

Patient:

* Under legal protection (curatorship, guardianship, safeguard of justice)
* Pregnant, parturient or breastfeeding woman
* Refusal to participate by the patient or their proxy (or an immediate family member)
* Cognitive disorders incompatible with the understanding of instructions
* Previously diagnosed swallowing disorders
* With a neurological condition at the origin of the SD (stroke, ALS...)
* Treated for a lesion of the aerodigestive tract (by surgery, radiotherapy or radio-chemotherapy)
* presence of wounds or dressings on the areas to be evaluated that prevent ultrasound measurements
* Patient for whom a decision to limit or stop life support treatments has been taken collegially within the intensive care unit
* With one or more contraindications to performing NF:

* Anatomical features not compatible with NF: mainly deviation of the nasal septum.
* Risk of significant otorhinolaryngological bleeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Dijon Bourgogne

Dijon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jose Arturo PINEDA MASEGOSA

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jose Arturo PINEDA MASEGOSA

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PINEDA APPARA 2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gastric US in ICU Patient
NCT05526105 RECRUITING NA